BIG3 inhibits insulin granule biogenesis and insulin secretion

Page view(s)
13
Checked on Jun 28, 2024
BIG3 inhibits insulin granule biogenesis and insulin secretion
Title:
BIG3 inhibits insulin granule biogenesis and insulin secretion
Journal Title:
EMBO reports
Keywords:
Publication Date:
07 April 2014
Citation:
Abstract:
While molecular regulation of insulin granule exocytosis is relatively well understood, insulin granule biogenesis and maturation and its influence on glucose homeostasis are relatively unclear. Here, we identify a novel protein highly expressed in insulin‐secreting cells and name it BIG3 due to its similarity to BIG/GBF of the Arf‐GTP exchange factor (GEF) family. BIG3 is predominantly localized to insulin‐ and clathrin‐positive trans‐Golgi network (TGN) compartments. BIG3‐deficient insulin‐secreting cells display increased insulin content and granule number and elevated insulin secretion upon stimulation. Moreover, BIG3 deficiency results in faster processing of proinsulin to insulin and chromogranin A to β‐granin in β‐cells. BIG3‐knockout mice exhibit postprandial hyperinsulinemia, hyperglycemia, impaired glucose tolerance, and insulin resistance. Collectively, these results demonstrate that BIG3 negatively modulates insulin granule biogenesis and insulin secretion and participates in the regulation of systemic glucose homeostasis.
License type:
PublisherCopyrights
Funding Info:
Description:
Full paper can be downloaded from the Publisher's URL provided.
ISSN:
1469-221X
1469-3178
Files uploaded:
File Size Format Action
There are no attached files.